Aarey Drugs & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2025
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has submitted the Scrutinizer's Report from its Annual General Meeting (AGM) held on September 29, 2025, to the stock exchange. This report typically contains the results of voting on resolutions put forward at the AGM, including their approval or rejection by shareholders. The filing is a routine regulatory compliance step required after every AGM. Specific voting numbers and resolution-wise outcomes would be detailed in the report itself.
This is a routine procedural disclosure and is unlikely to have a meaningful impact on the stock price, unless the report contains unexpected voting surprises on key resolutions.